Santiago Dexeus Font Foundation
This randomized trial was designed as a no-inferiority trial aiming to evaluate if the intensity of stimulation (a milder vs a more intense approach) may have an impact on the number of euploid embryos and the morpho kinetic parameters in advanced age women undergoing PGT-A with a PPOS protocol.
Fertility
Follitropin-delta (Rekovelle) 20 mcg/day from D1
Follitropin-delta (Rekovelle) 15 mcg/day from D1
PHASE4
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 110 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | The Impact of Ovarian Stimulation Intensity on Embryo Euploidy in Advanced Age Women |
Actual Study Start Date : | 2023-12-12 |
Estimated Primary Completion Date : | 2025-12-15 |
Estimated Study Completion Date : | 2026-05-15 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 38 Years to 42 Years |
Sexes Eligible for Study: | FEMALE |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
University Hospital Quiron Dexeus
Barcelona, Spain, 08028